TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive House Appropriations For NCI Identical (So Far) To White House Request; Slight Increase for NIH June 24, 1988
TCL Archive ACS Finds 1 In 4 US Deaths From Cancer; Weiss Named NCI Centers Branch Chief. January 18, 2002
